Cell>Point provides updates on 2 agents

04/27/2010 | KMGH-TV (Denver)

Cell>Point has developed two agents that in the future could be combined to identify and treat cancer cells. The first agent, a SPECT imaging agent, has completed the final clinical study and could be available to doctors in the latter part of the year. The second agent, a therapeutic one, is set to enter Phase I of clinical studies.

View Full Article in:

KMGH-TV (Denver)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA